Kewl 3 of My Favourite Canadian Stocks to Buy Today
Boralex  TSX:BLX  is a Montreal-based company that is engaged in the development, construction, and operation of renewable energy power facilities primarily in Canada, France, and the United States. Today, I want to discuss why I m looking to snatch up this renewable energy stock to kick stanley cup  off the New Year. Let s jump in.How did Boralex stock perform in 2022 Shares of Boralex opened at $34.39 per share when trading began on January 4, 2022. The stock would close at $40.94 on December 29, 2022. This means that the stock climbed 19% over the course of the previous year. That is a solid  vaso stanley performance in the face of a very challenging year for most domestic and global equities.Readers who want more information on its performance can play with the interactive chart that trac stanley cup ks the stock s recent price fluctuations below.This renewable energy stock is a buy-the-dip opportunityBoralex stock rose 19% in 2022, but it still suffered a sharp drop after hitting a 52-week high of $51.55 in late August  Lwcp If I d Invested in CNQ Stock at the Start of 2022, Here s What I d Have Now
There are growing fears among investors and market pundits that the massive marijuana bubble has reached an abrupt end. Canopy Growth  TSX:WEED  NYSE:CGC  has lost 6% over the last month after releasing some disappointing fiscal fourth quarter 2019 results, including a whopping $670 million loss that was more than 12 times greater th stanley cup quencher an a year earlier.That loss saw co-founder and co-CEO Bruce Linton step down from Canada s leading legal cannabis cultivator as the board, led by 40% owner liquor giant Constellation Brands, which expressed their disappointment in the company s perform stanley thermos ance.Are investors losing confidence Now medical stanley thermobecher  marijuana cultivator CannTrust has been found by Health Canada to have been cultivating cannabis in breach of its regulatory obligations, triggering further market dismay with marijuana stocks. This comes only months after a controversial research report claimed that Canada s second-largest cultivator Aphria  TSX:APHA  NYSE:APHA  was a  shell game with a cannabi

Kewl 3 of My Favourite Canadian Stocks to Buy Today
Boralex  TSX:BLX  is a Montreal-based company that is engaged in the development, construction, and operation of renewable energy power facilities primarily in Canada, France, and the United States. Today, I want to discuss why I m looking to snatch up this renewable energy stock to kick stanley cup  off the New Year. Let s jump in.How did Boralex stock perform in 2022 Shares of Boralex opened at $34.39 per share when trading began on January 4, 2022. The stock would close at $40.94 on December 29, 2022. This means that the stock climbed 19% over the course of the previous year. That is a solid  vaso stanley performance in the face of a very challenging year for most domestic and global equities.Readers who want more information on its performance can play with the interactive chart that trac stanley cup ks the stock s recent price fluctuations below.This renewable energy stock is a buy-the-dip opportunityBoralex stock rose 19% in 2022, but it still suffered a sharp drop after hitting a 52-week high of $51.55 in late August  Lwcp If I d Invested in CNQ Stock at the Start of 2022, Here s What I d Have Now
There are growing fears among investors and market pundits that the massive marijuana bubble has reached an abrupt end. Canopy Growth  TSX:WEED  NYSE:CGC  has lost 6% over the last month after releasing some disappointing fiscal fourth quarter 2019 results, including a whopping $670 million loss that was more than 12 times greater th stanley cup quencher an a year earlier.That loss saw co-founder and co-CEO Bruce Linton step down from Canada s leading legal cannabis cultivator as the board, led by 40% owner liquor giant Constellation Brands, which expressed their disappointment in the company s perform stanley thermos ance.Are investors losing confidence Now medical stanley thermobecher  marijuana cultivator CannTrust has been found by Health Canada to have been cultivating cannabis in breach of its regulatory obligations, triggering further market dismay with marijuana stocks. This comes only months after a controversial research report claimed that Canada s second-largest cultivator Aphria  TSX:APHA  NYSE:APHA  was a  shell game with a cannabi